Have you been diagnosed with a brain tumour? Order your free information pack.

Adjuvant immunotherapy

Adjuvant immunotherapies are substances that are either used alone, or in combination with other immunotherapies, to improve their response.

How do adjuvant immunotherapies work?

Some adjuvant immunotherapies use ‘ligands’ to boost immune responses. Ligands are molecules that can bind to protein receptors on cells, with names such as ‘toll-like receptors (TLRs)’. These are molecules that are used to boost the body’s immune response. They have shown some effectiveness in brain, kidney, lung, colon, pancreatic, prostate, ovarian and breast cancer.

Checkpoint inhibitors come under this broad category.

Adjuvant immunotherapies hope to improve responses to cancer vaccines that use T-cells or other immune cells.

Make the right choices for you

Our Step by Step interactive guide outlines what happens following a brain tumour diagnosis. It also answers your questions and helps you to understand what to expect.

If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:
Support and Information Services
0808 800 0004 Free from landlines and mobiles
Phone lines open Mon-Fri, 09:00-17:00

Share your experiences and help create change

By taking part in our Improving Brain Tumour Care surveys and sharing your experiences, you can help us improve treatment and care for everyone affected by a brain tumour.